Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBT (2018 - 2025)

Historic EBT for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to -$15.6 million.

  • Evolus' EBT rose 1820.76% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.8 million, marking a year-over-year decrease of 489.75%. This contributed to the annual value of -$49.8 million for FY2024, which is 1910.78% up from last year.
  • Evolus' EBT amounted to -$15.6 million in Q3 2025, which was up 1820.76% from -$17.1 million recorded in Q2 2025.
  • Evolus' EBT's 5-year high stood at $6.4 million during Q1 2021, with a 5-year trough of -$23.4 million in Q2 2022.
  • Over the past 5 years, Evolus' median EBT value was -$16.9 million (recorded in 2023), while the average stood at -$14.9 million.
  • In the last 5 years, Evolus' EBT soared by 13292.26% in 2021 and then plummeted by 37293.0% in 2022.
  • Over the past 5 years, Evolus' EBT (Quarter) stood at -$18.2 million in 2021, then increased by 27.86% to -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then soared by 45.83% to -$6.4 million in 2024, then crashed by 145.16% to -$15.6 million in 2025.
  • Its last three reported values are -$15.6 million in Q3 2025, -$17.1 million for Q2 2025, and -$18.8 million during Q1 2025.